Mounjaro®
Starting from £179.99/mo
Start journey Learn moreA burning sensation at the Wegovy injection site is one of the most commonly reported local reactions, and for most people it lasts only a minute or two after the pen clicks. It does not usually mean something is wrong. That said, understanding what's behind the burning, and knowing the difference between a minor skin reaction and a sign that something needs attention, makes the whole experience far less unsettling. Wegovy (semaglutide) is a prescription-only medicine, so any local reactions that worry you are worth raising with your prescriber rather than guessing at from a search engine.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most people who feel a sting or burn at the site assume they have done something incorrectly. Injected at the wrong angle, perhaps, or hit a nerve. In practice, local stinging with Wegovy is so common that it is listed explicitly in the product information as an injection-site reaction, alongside redness and itching. The formulation itself, a liquid containing semaglutide and a carrier solution, can provoke a brief sensory response in the skin regardless of technique.
The nerves just beneath the skin are doing their job. They detect the fluid, flag a mild alert and the feeling passes. It is not a sign of infection, an allergic response or a dosing error. Infection would typically arrive hours later with spreading redness, warmth that doesn't settle and tenderness to touch. A true allergic reaction tends to involve the wider body: hives, swelling of the face or throat, difficulty breathing. A momentary sting is neither of those.
Where technique does make a genuine difference is in the intensity and frequency of that sting, which is worth addressing. The choice of injection site matters more than many people realise, and small adjustments can take discomfort from noticeable to barely there.
Cold medicine is the single most cited trigger for sharper injection discomfort. Wegovy pens are stored in the fridge, and injecting a cold liquid into skin tissue irritates those superficial nerve endings more than a pen that has been left out for 20 to 30 minutes. The NHS guidance on weight-management injections confirms that allowing the pen to warm to room temperature before use can reduce local reactions — and this is one check that takes no equipment and under a minute: hold the pen in your palm, not against your palm briefly, actually cup it and count to sixty. It will not resolve the burning entirely for everyone, but it consistently reduces it.
Injecting into the same spot repeatedly is another factor. Scar tissue builds gradually and tends to produce sharper sensations. Rotating weekly between the abdomen, the thigh and the upper arm distributes that load. If you have been favouring one area, a dedicated page on using the upper arm as an injection site covers technique for that location specifically.
Needle length and angle also play a role for some people. A slower, steadier injection rather than a rapid push can reduce the sudden pressure sensation in the tissue. Make sure the needle is changed for every injection rather than reused; reused needles develop microscopic barbs that increase skin trauma. Fresh needles matter more than most people appreciate, and changing the needle every time is straightforward to keep on top of.
Speed of injection counts too. Pressing the button and immediately withdrawing tends to amplify burning. Holding the pen in place for a full ten seconds after the click, then withdrawing steadily, allows the medicine to disperse before the needle tip moves.
The NHS medicines page for semaglutide lists injection-site reactions including redness, swelling, bruising and itching as common side effects. Common means they affect more than one person in a hundred. Most resolve on their own within a few hours.
The pattern to watch for is persistence and spread. Redness that covers more than a few centimetres, warmth that intensifies over hours rather than fading, or skin that becomes raised and tender to the touch the following day — these are not typical of a routine injection-site reaction and are worth discussing with your prescriber before your next dose. Similarly, bruising at the injection site is its own distinct reaction worth understanding separately from burning.
A hard lump under the skin (lipohypertrophy) that develops after repeated injections into the same spot can also feel sensitive and may affect how the medicine absorbs. Rotating sites prevents it from developing; once present, avoiding that spot usually allows it to resolve over weeks.
If you experience any swelling of your face, lips or tongue, a rash across your body, or difficulty breathing at any point after injecting, treat it as an urgent medical situation and call 999. These signs suggest an anaphylactic response, which is rare but requires immediate help, not a wait to see if it settles.
Occasional stinging that fades quickly is not a reason to delay or avoid your injection. Skipping doses disrupts your titration and can lead to returning symptoms or a need to step down to a lower dose. The question to bring to your prescriber is not whether to continue, but whether there are adjustments, such as injection site, technique or pen-warming practice, that would make each dose more comfortable.
At nume, a GPhC-registered prescriber personally reads every consultation and every follow-up question; your concern does not pass through an automated triage system. If you are already on treatment elsewhere and want a clinical team that reviews every repeat before dispensing, our clinical oversight approach explains how that works. For those considering starting Wegovy and wanting to understand the full picture before committing, our Wegovy treatment overview covers the evidence, the eligibility criteria and the process in detail.
Cost is a reasonable question too. A dedicated page on Wegovy pricing in the UK explains why wide variation in headline prices exists and what a legitimate treatment package should include. And if you have broader questions about the injection experience, our guide to the Wegovy injection site covers the practical detail that the patient information leaflet does not always make obvious.
If you are ready to speak to a prescriber, start your free consultation and a clinician will review your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.